RecruitingHematologic MalignanciesLymphomaMultiple Myeloma
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
Eligible age
60+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to evaluate whether a novel decision support tool called PRIME (Preference Reporting to Improve Management and Experience), which combines values-elicitation with tailored feedback to patients and providers, improves patient-reported values-concordance of initial treatment decisions compared to usual care.
Sponsor: UNC Lineberger Comprehensive Cancer Center
You may qualify if…
- ✓ 1. Written or verbal informed consent obtained to participate in the study and HIPAA authorization for the release of personal health information.
- ✓ 2. Subjects are willing and able to comply with study procedures based on the judgment of the investigator.
- ✓ 3. Age ≥ 60 years at the time of consent.
- ✓ 4. New patient to either the hematologic malignancies clinic or the bone marrow transplant/cellular therapy clinic.
You may not qualify if…
- ✕ All subjects meeting any of the exclusion criteria listed below at baseline will be excluded from study participation:
- ✕ 1\. Dementia, altered mental status, or psychiatric condition that would prohibit the understanding or rendering of informed consent or participation in the intervention.
Where it's recruiting
North Carolina
Chapel Hill
Source: ClinicalTrials.gov · NCT06296368 · last updated 2026-08-14